{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T15:42:17Z","timestamp":1787499737633,"version":"build-2736575974"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2022,7,25]],"date-time":"2022-07-25T00:00:00Z","timestamp":1658707200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,7,25]],"date-time":"2022-07-25T00:00:00Z","timestamp":1658707200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002345","name":"Eberhard Karls Universit\u00e4t T\u00fcbingen","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100002345","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cancer Res Clin Oncol"],"published-print":{"date-parts":[[2023,7]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>In pediatric bladder\/prostate-rhabdomyosarcoma, the rate of bladder preservation after neoadjuvant chemotherapy is high, with an excellent oncological outcome. Information about functional urological long-term outcomes is rare.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Data of all patients who had undergone bladder-preserving surgery with or without brachytherapy at our institution between 2009 and 2020 were analyzed retrospectively. Detailed urological function was assessed focusing on age-related continence, bladder capacity and urodynamic findings.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>We identified 40 patients, median age at surgery of 27\u00a0months (range 9\u2013191), and 32 patients additionally received postoperative high-dose-rate brachytherapy. The median follow-up was 32.5\u00a0months (range 6\u2013125). The bladder capacity increased from median 66.7% (21.1\u2013180) of expected bladder capacity related to age 3\u00a0months after surgery to 87.4%\u00a0(58.1\u2013181.8) 9\u00a0months after surgery. In the group of aged\u2009&gt;\u20096-year-old, continence was 94% (83% with brachytherapy, 100% without brachytherapy). Erectile function was normal in 92% (90% with brachytherapy, 100% without brachytherapy). Bladder capacity was more than 65% expected bladder capacity related to age in 70% (60% with brachytherapy, 86% without brachytherapy). 65% of all patients need neither anticholinergic drugs nor low-dose antibiotics (63% with brachytherapy, 71% without brachytherapy).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Bladder preservation with good functional outcome can be achieved in localized bladder\/prostate-rhabdomyosarcoma. In selected cases, supportive brachytherapy additionally contributes to an improvement in the oncological outcome with calculable risks for bladder and erectile function. Careful urological aftercare should be a fixed priority after oncological follow-ups.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s00432-022-04209-5","type":"journal-article","created":{"date-parts":[[2022,7,25]],"date-time":"2022-07-25T15:02:52Z","timestamp":1658761372000},"page":"3161-3170","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Detailed functional results after bladder-preserving surgery and high-dose-rate brachytherapy in pediatric bladder\/prostate rhabdomyosarcoma"],"prefix":"10.1007","volume":"149","author":[{"given":"Verena","family":"Ellerkamp","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven W.","family":"Warmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franziska","family":"Eckert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juergen","family":"Schaefer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Paulsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joerg","family":"Fuchs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,7,25]]},"reference":[{"key":"4209_CR1","doi-asserted-by":"publisher","first-page":"2396","DOI":"10.1097\/01.ju.0000127752.41749.a4","volume":"171","author":"C Arndt","year":"2004","unstructured":"Arndt C, Rodeberg D, Breitfeld PP, Raney RB, Ullrich F, Donaldson S (2004) Does bladder preservation (as a surgical principle) lead to retaining bladder function in bladder\/prostate rhabdomyosarcoma? Results from intergroup rhabdomyosarcoma study iv. J Urol 171:2396\u20132403","journal-title":"J Urol"},{"key":"4209_CR2","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1002\/nau.22751","volume":"35","author":"PF Austin","year":"2016","unstructured":"Austin PF, Bauer SB, Bower W, Chase J, Franco I, Hoebeke P, Rittig S, Walle JV, von Gontard A, Wright A, Yang SS, Nev\u00e9us T (2016) The standardization of terminology of lower urinary tract function in children and adolescents: update report from the standardization committee of the international children\u2019s continence society. Neurourol Urodyn 35:471\u2013481","journal-title":"Neurourol Urodyn"},{"key":"4209_CR3","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1097\/MOU.0000000000000651","volume":"29","author":"M Castagnetti","year":"2019","unstructured":"Castagnetti M, Herbst KW, Esposito C (2019) Current treatment of pediatric bladder and prostate rhabdomyosarcoma (bladder preserving vs. radical cystectomy). Curr Opin Urol 29:487\u2013492","journal-title":"Curr Opin Urol"},{"key":"4209_CR4","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1016\/j.ijrobp.2017.02.026","volume":"98","author":"C Chargari","year":"2017","unstructured":"Chargari C, Haie-Meder C, Guerin F, Minard-Colin V, de Lambert G, Mazeron R, Escande A, Marsolat F, Dumas I, Deutsch E, Valteau-Couanet D, Audry G, Oberlin O, Martelli H (2017) Brachytherapy combined with surgery for conservative treatment of children with bladder neck and\/or prostate rhabdomyosarcoma. Int J Radiat Oncol Biol Phys 98:352\u2013359","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"4209_CR5","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1016\/j.ijrobp.2010.07.1989","volume":"81","author":"SE Cotter","year":"2011","unstructured":"Cotter SE, Herrup DA, Friedmann A, Macdonald SM, Pieretti RV, Robinson G, Adams J, Tarbell NJ, Yock TI (2011) Proton radiotherapy for pediatric bladder\/prostate rhabdomyosarcoma: clinical outcomes and dosimetry compared to intensity-modulated radiation therapy. Int J Radiat Oncol Biol Phys 81:1367\u20131373","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"4209_CR6","doi-asserted-by":"publisher","first-page":"3091","DOI":"10.1200\/JCO.2001.19.12.3091","volume":"19","author":"WM Crist","year":"2001","unstructured":"Crist WM, Anderson JR, Meza JL, Fryer C, Raney RB, Ruymann FB, Breneman J, Qualman SJ, Wiener E, Wharam M, Lobe T, Webber B, Maurer HM, Donaldson SS (2001) Intergroup rhabdomyosarcoma study-IV: results for patients with nonmetastatic disease. J Clin Oncol 19:3091\u20133102","journal-title":"J Clin Oncol"},{"key":"4209_CR7","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1097\/01.sla.0000133083.54934.ae","volume":"240","author":"D Dindo","year":"2004","unstructured":"Dindo D, Demartines N, Clavien PA (2004) Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240:205\u2013213","journal-title":"Ann Surg"},{"key":"4209_CR8","doi-asserted-by":"publisher","first-page":"1847","DOI":"10.1200\/JCO.1990.8.11.1847","volume":"8","author":"F Flamant","year":"1990","unstructured":"Flamant F, Gerbaulet A, Nihoul-Fekete C, Valteau-Couanet D, Chassagne D, Lemerle J (1990) Long-term sequelae of conservative treatment by surgery, brachytherapy, and chemotherapy for vulval and vaginal rhabdomyosarcoma in children. J Clin Oncol 8:1847\u20131853","journal-title":"J Clin Oncol"},{"key":"4209_CR9","doi-asserted-by":"publisher","first-page":"404.e1","DOI":"10.1016\/j.jpurol.2016.07.002","volume":"12","author":"S Frees","year":"2016","unstructured":"Frees S, Rubenwolf P, Ziesel C, Faber J, Gutjahr P, Grossmann A, Thuroff JW, Stein R (2016) Erectile function after treatment for rhabdomyosarcoma of prostate and bladder. J Pediatr Urol 12:404.e1\u201304.e6","journal-title":"J Pediatr Urol"},{"key":"4209_CR10","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.radonc.2016.10.010","volume":"121","author":"J Fuchs","year":"2016","unstructured":"Fuchs J, Paulsen F, Bleif M, Lamprecht U, Weidner N, Zips D, Neunhoeffer F, Seitz G (2016) Conservative surgery with combined high dose rate brachytherapy for patients suffering from genitourinary and perianal rhabdomyosarcoma. Radiother Oncol 121:262\u2013267","journal-title":"Radiother Oncol"},{"key":"4209_CR11","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1007\/s00066-011-2261-3","volume":"187","author":"F Heinzelmann","year":"2011","unstructured":"Heinzelmann F, Thorwarth D, Lamprecht U, Kaulich TW, Fuchs J, Seitz G, Ebinger M, Handgretinger R, Bamberg M, Weinmann M (2011) Comparison of different adjuvant radiotherapy approaches in childhood bladder\/prostate rhabdomyosarcoma treated with conservative surgery. Strahlenther Onkol 187:715\u2013721","journal-title":"Strahlenther Onkol"},{"key":"4209_CR12","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1016\/j.ijrobp.2019.12.036","volume":"106","author":"DJ Indelicato","year":"2020","unstructured":"Indelicato DJ, Rotondo RL, Krasin MJ, Mailhot Vega RB, Uezono H, Bradfield S, Agarwal V, Morris CG, Bradley JA (2020) Outcomes following proton therapy for group III pelvic rhabdomyosarcoma. Int J Radiat Oncol Biol Phys 106:968\u2013976","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"4209_CR13","doi-asserted-by":"publisher","first-page":"245","DOI":"10.5114\/jcb.2021.105846","volume":"13","author":"B Johansson","year":"2021","unstructured":"Johansson B, Ols\u00e9n JS, Karlsson L, Lundin E, Lennern\u00e4s B (2021) High-dose-rate brachytherapy as monotherapy for low- and intermediate-risk prostate cancer: long-term experience of Swedish single-center. J Contemp Brachytherapy 13:245\u2013253","journal-title":"J Contemp Brachytherapy"},{"key":"4209_CR14","volume-title":"CWS-guidance for risk adapted treatment of soft tissue sarcoma and soft tissue tumours in children adolescents and young adults version 1.6.1","author":"E Koscielniak","year":"2014","unstructured":"Koscielniak E, Klingebiel T (2014) CWS-guidance for risk adapted treatment of soft tissue sarcoma and soft tissue tumours in children adolescents and young adults version 1.6.1. Cooperative Weichteilsarkom Studie Group, Stuttgart, Germany"},{"key":"4209_CR15","volume-title":"Textbook of the neurogenic bladder","author":"SP Lapointe","year":"2005","unstructured":"Lapointe SP, Barrieras D (2005) Normal urodynamic parameters in children. In: Corcos J, Schick E (eds) Textbook of the neurogenic bladder. Martin Dunitz Taylor Francis Group"},{"key":"4209_CR16","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.urology.2016.05.021","volume":"95","author":"MS Leapman","year":"2016","unstructured":"Leapman MS, Stone NN, Mock S, Stock RG, Hall SJ (2016) Urinary incontinence following prostate brachytherapy. Urology 95:151\u2013157","journal-title":"Urology"},{"key":"4209_CR17","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.29574","author":"S Lobo","year":"2022","unstructured":"Lobo S, Gaze MN, Slater O, Hoskin P, Sands G, Sullivan T, Cho A, Eminowicz G, Smeulders N (2022) Bladder function after conservative surgery and high-dose rate brachytherapy for bladder-prostate rhabdomyosarcoma. Pediatr Blood Cancer. https:\/\/doi.org\/10.1002\/pbc.29574","journal-title":"Pediatr Blood Cancer"},{"key":"4209_CR18","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1016\/j.clon.2019.03.047","volume":"31","author":"HC Mandeville","year":"2019","unstructured":"Mandeville HC (2019) Radiotherapy in the management of childhood rhabdomyosarcoma. Clin Oncol (r Coll Radiol) 31:462\u2013470","journal-title":"Clin Oncol (r Coll Radiol)"},{"key":"4209_CR19","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.jpedsurg.2008.10.040","volume":"44","author":"H Martelli","year":"2009","unstructured":"Martelli H, Haie-Meder C, Branchereau S, Franchi-Abella S, Ghigna MR, Dumas I, Bouvet N, Oberlin O (2009) Conservative surgery plus brachytherapy treatment for boys with prostate and\/or bladder neck rhabdomyosarcoma: a single team experience. J Pediatr Surg 44:190\u2013196","journal-title":"J Pediatr Surg"},{"key":"4209_CR20","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.brachy.2016.01.001","volume":"15","author":"H Martelli","year":"2016","unstructured":"Martelli H, Borrego P, Guerin F, Boubnova J, Minard-Colin V, Dumas I, Chargari C, Haie-Meder C (2016) Quality of life and functional outcome of male patients with bladder-prostate rhabdomyosarcoma treated with conservative surgery and brachytherapy during childhood. Brachytherapy 15:306\u2013311","journal-title":"Brachytherapy"},{"key":"4209_CR21","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10092028","author":"BA Martin-Giacalone","year":"2021","unstructured":"Martin-Giacalone BA, Weinstein PA, Plon SE, Lupo PJ (2021) Pediatric rhabdomyosarcoma: epidemiology and genetic susceptibility. J Clin Med. https:\/\/doi.org\/10.3390\/jcm10092028","journal-title":"J Clin Med"},{"key":"4209_CR22","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1016\/j.brachy.2017.02.004","volume":"16","author":"AO Naghavi","year":"2017","unstructured":"Naghavi AO, Fernandez DC, Mesko N, Juloori A, Martinez A, Scott JG, Shah C, Harrison LB (2017) American Brachytherapy Society consensus statement for soft tissue sarcoma brachytherapy. Brachytherapy 16:466\u2013489","journal-title":"Brachytherapy"},{"key":"4209_CR23","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1002\/ijc.25444","volume":"128","author":"DA Rodeberg","year":"2011","unstructured":"Rodeberg DA, Anderson JR, Arndt CA, Ferrer FA, Raney RB, Jenney ME, Brecht IB, Koscielniak E, Carli M, Bisogno G, Oberlin O, Rey A, Ullrich F, Stevens MC, Meyer WH (2011) Comparison of outcomes based on treatment algorithms for rhabdomyosarcoma of the bladder\/prostate: combined results from the children\u2019s oncology group, German cooperative soft tissue sarcoma study, Italian cooperative group, and international society of pediatric oncology malignant mesenchymal tumors committee. Int J Cancer 128:1232\u20131239","journal-title":"Int J Cancer"},{"key":"4209_CR24","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s11934-018-0761-8","volume":"19","author":"AF Saltzman","year":"2018","unstructured":"Saltzman AF, Cost NG (2018) Current treatment of pediatric bladder and prostate rhabdomyosarcoma. Curr Urol Rep 19:11","journal-title":"Curr Urol Rep"},{"key":"4209_CR25","doi-asserted-by":"publisher","DOI":"10.1097\/JU.0000000000001127","author":"A Schmidt","year":"2020","unstructured":"Schmidt A, Warmann SW, Eckert F, Ellerkamp V, Schaefer J, Blumenstock G, Paulsen F, Fuchs J (2020) The role of reconstructive surgery and brachytherapy in pediatric bladder\/prostate rhabdomyosarcoma. J Urol. https:\/\/doi.org\/10.1097\/JU.0000000000001127","journal-title":"J Urol"},{"key":"4209_CR26","doi-asserted-by":"publisher","first-page":"4067","DOI":"10.1245\/s10434-016-5391-0","volume":"23","author":"G Seitz","year":"2016","unstructured":"Seitz G, Fuchs J, Sparber-Sauer M, Leuschner I, Godzinski J, Klingebiel T, Schuck A, Martus P, Dantonello TM, Koscielniak E (2016) Improvements in the treatment of patients suffering from bladder-prostate rhabdomyosarcoma: a report from the CWS-2002P trial. Ann Surg Oncol 23:4067\u20134072","journal-title":"Ann Surg Oncol"},{"key":"4209_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2022.01.034","author":"J Stenman","year":"2022","unstructured":"Stenman J, Wickart-Johansson G, Sundquist F, Nilsson J, Ljungman G, \u00d6sterlundh G, Jaln\u00e4s M, Pal N, Mercke C (2022) Five-year follow-up after multimodal treatment incorporating HDR brachytherapy for bladder prostate rhabdomyosarcoma in children. Int J Radiat Oncol Biol Phys. https:\/\/doi.org\/10.1016\/j.ijrobp.2022.01.034","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"4209_CR28","doi-asserted-by":"publisher","first-page":"3391","DOI":"10.1200\/JCO.2008.19.7483","volume":"27","author":"I Sultan","year":"2009","unstructured":"Sultan I, Qaddoumi I, Yaser S, Rodriguez-Galindo C, Ferrari A (2009) Comparing adult and pediatric rhabdomyosarcoma in the surveillance, epidemiology and end results program, 1973 to 2005: an analysis of 2600 patients. J Clin Oncol 27:3391\u20133397","journal-title":"J Clin Oncol"},{"key":"4209_CR29","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.urology.2019.01.022","volume":"126","author":"H Taniguchi","year":"2019","unstructured":"Taniguchi H, Kawakita S, Kinoshita H, Murota T, Matsuda T (2019) Testosterone profiles after brachytherapy for localized prostate cancer. Urology 126:121\u2013127","journal-title":"Urology"},{"key":"4209_CR30","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.29412","volume":"69","author":"SJ Zakem","year":"2022","unstructured":"Zakem SJ, Cost CR, Cost NG, Robin TP, Milgrom SA (2022) Brachytherapy in children, adolescents, and young adults: an underutilized modality in the United States? Pediatr Blood Cancer 69:e29412","journal-title":"Pediatr Blood Cancer"}],"container-title":["Journal of Cancer Research and Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-022-04209-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00432-022-04209-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-022-04209-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T08:06:26Z","timestamp":1688198786000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00432-022-04209-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,25]]},"references-count":30,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2023,7]]}},"alternative-id":["4209"],"URL":"https:\/\/doi.org\/10.1007\/s00432-022-04209-5","relation":{},"ISSN":["0171-5216","1432-1335"],"issn-type":[{"value":"0171-5216","type":"print"},{"value":"1432-1335","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,25]]},"assertion":[{"value":"20 June 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 July 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 July 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of University Tuebingen (No. 353\/2019BO2).","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"In agreement with the ethics committee, patient consent to publish was waived due to the retrospective and observational character of the study and the pseudonymization. The necessity for written informed consent was waived due to the retrospective nature from the study. The research was completed using collected and pseudonymized data.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}}]}}